Clinical trial
Study of the Prognostic Value of the Coagulolytic Balance Dependent on Circulating Microvesicles in the Occurrence of Thrombotic Events After Total Knee Replacement in Orthopedic Surgery.
NCT05387694 is registered in ClinicalTrials.gov with Assistance Publique Hopitaux De Marseille as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of the Prognostic Value of the Coagulolytic Balance Dependent on Circulating Microvesicles in the Occurrence of Thrombotic Events After Total Knee Replacement in Orthopedic Surgery.
- Lead sponsor
- Assistance Publique Hopitaux De Marseille
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- June 30, 2023
- Completion date
- December 31, 2026
- Enrollment
- 387 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
knee prosthesis